157 related articles for article (PubMed ID: 3001454)
1. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
Koch HP; Bachner J; Löffler E
Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
Heyliger CE; Panagia V; Dhalla NS
J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
4. Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase.
Beretz A; Anton R; Stoclet JC
Experientia; 1978 Aug; 34(8):1054-5. PubMed ID: 212288
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of rat heart and brain cyclic 3',5'-adenosine monophosphate phosphodiesterase under the influence of neurohormone "C"].
Galoian AA; Gurvits BIa; Pogosian MA
Vopr Biokhim Mozga; 1976; 11():89-96. PubMed ID: 203105
[TBL] [Abstract][Full Text] [Related]
6. Interactions of chlorphenesin and divalent metal ions with phosphodiesterase.
Edelson J; McMullen JP
Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):24-33. PubMed ID: 187130
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of adenosine-3',5'-cyclic monophosphate phosphodiesterase by potential antiallergic compounds.
Tateson JE; Trist DG
Life Sci; 1976 Jan; 18(2):153-61. PubMed ID: 56695
[No Abstract] [Full Text] [Related]
10. Structure/activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices.
Ferrell JE; Chang Sing PD; Loew G; King R; Mansour JM; Mansour TE
Mol Pharmacol; 1979 Sep; 16(2):556-68. PubMed ID: 229402
[No Abstract] [Full Text] [Related]
11. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
Nemoz G; Prigent AF
Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
[No Abstract] [Full Text] [Related]
12. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
Adachi K; Numano F
Jpn J Pharmacol; 1977 Feb; 27(1):97-103. PubMed ID: 194077
[TBL] [Abstract][Full Text] [Related]
13. Effect of papaverine analogues on 3', 5'-adenosine monophosphate phosphodiesterase activity in rat brain.
Stancheva S; Uzunov P; Stoytchev T
Acta Physiol Pharmacol Bulg; 1980; 6(1):41-7. PubMed ID: 6250318
[TBL] [Abstract][Full Text] [Related]
14. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
McNeill JH; Brenner MJ; Muschek LD
Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
[No Abstract] [Full Text] [Related]
15. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries.
Bartel S; Tenor H; Krause EG
Biomed Biochim Acta; 1985; 44(5):K31-5. PubMed ID: 2415118
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 3',5'-AMP phosphodiesterase by biflavonoids and xanthones.
Beretz A; Joly M; Stoclet JC; Anton R
Planta Med; 1979 Jul; 36(3):193-5. PubMed ID: 225754
[No Abstract] [Full Text] [Related]
17. The influence of nicergoline on reaction kinetics of various forms of cyclic AMP phosphodiesterase.
Pericin D; Leskovac V
Arzneimittelforschung; 1981; 31(12):2082-5. PubMed ID: 6277342
[TBL] [Abstract][Full Text] [Related]
18. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC
Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug interactions of silymarin on the perspective of pharmacokinetics.
Wu JW; Lin LC; Tsai TH
J Ethnopharmacol; 2009 Jan; 121(2):185-93. PubMed ID: 19041708
[TBL] [Abstract][Full Text] [Related]
20. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
Kidd P; Head K
Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
